Ultrahigh-Resolution CCTA Has High Diagnostic Accuracy for Coronary Artery Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 21, 2023 -- For patients at high risk for coronary artery disease (CAD), ultrahigh-resolution (UHR) photon-counting coronary computed tomography angiography (CCTA) has high diagnostic accuracy, according to a study published online June 20 in Radiology.
Muhammad Taha Hagar, M.D., from the Medical Center-University of Freiburg in Germany, and colleagues enrolled patients with severe aortic valve stenosis and clinically indicated CT for transcatheter aortic valve replacement planning in a prospective study. A dual-source photon-counting CT scanner was used to examine all participants using a retrospective electrocardiography-gated contrast-enhanced UHR scanning protocol. As part of their clinical routine, patients also underwent invasive coronary angiography (ICA). Area under the receiver operating characteristic curve (AUC) was used to compare UHR CCTA to ICA.
The researchers found that the prevalence of CAD and prior stent placement was 35 and 22 percent, respectively, among 68 participants. Image quality was excellent overall (median score, 1.5). For detection of CAD, the AUC of UHR CCTA was 0.93 per participant, 0.94 per vessel, and 0.92 per segment. The sensitivity, specificity, and accuracy, respectively, were 96, 84, and 88 percent per participant; 89, 91, and 91 percent per vessel; and 77, 95, and 95 percent per segment.
"It appears that the spectrum of patients benefiting from undergoing noninvasive CCTA has been significantly broadened by photon-counting detector technology," Hagar said in a statement. "This is excellent news for these patients and the imaging community."
Several authors disclosed ties to pharmaceutical and medical device companies, including Bayer Healthcare, which funded the study.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization
FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.